{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:32:52Z","timestamp":1771342372626,"version":"3.50.1"},"reference-count":35,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T00:00:00Z","timestamp":1253145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ther Apher Dial"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The calcium\u2010sensing receptor (CaR) on the parathyroid cell surface senses ionized calcium concentration in the extracellular fluid and regulates minute\u2010to\u2010minute parathyroid hormone (PTH) secretion. Synthetic allosteric modulators of CaR have been developed, and one of the positive modulators (calcimimetics) is cinacalcet HCl or cinacalcet. Cinacalcet increases the sensitivity of CaR to be activated by extracellular calcium, and thus suppresses PTH release. Cinacalcet is an effective treatment for secondary hyperparathyroidism (SHPT) in patients with uremia on hemodialysis. In this review, based on basic experiments using cinacalcet, we postulate the beneficial effects of cinacalcet on hyperfunctioning parathyroid diseases.<\/jats:p>","DOI":"10.1111\/j.1744-9987.2009.00768.x","type":"journal-article","created":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T05:22:07Z","timestamp":1253251327000},"source":"Crossref","is-referenced-by-count":5,"title":["Cinacalcet in Hyperfunctioning Parathyroid Diseases"],"prefix":"10.1111","volume":"13","author":[{"given":"Yasuo","family":"Imanishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehisa","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,9,17]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000414"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v31.pm9531176"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422003"},{"issue":"10","key":"e_1_2_10_5_2","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO4, Ca\u2003\u00d7\u2003PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh SK","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031633"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004060512"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh966"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03591006"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1517\/17460440903022743"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-56-3-572"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020881"},{"issue":"12","key":"e_1_2_10_13_2","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben\u2010Dov IZ","year":"2007","journal-title":"J Clin Invest"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006070783"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.5.2000"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.4.1598"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117890"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.5.1766"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000018148.50109.C0"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/366575a0"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90617-Y"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1295-389"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2001.280.2.F291"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.11.3107"},{"issue":"1","key":"e_1_2_10_25_2","first-page":"197","article-title":"Involvement of polyamines in the proliferation of bovine parathyroid cells","volume":"21","author":"Imanishi Y","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(99)00112-0"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.057273"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-006-0687-y"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.71"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.67103.x"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00782.x"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.407"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02007"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10523"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M400724200"},{"issue":"1","key":"e_1_2_10_36_2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-3565(24)29333-2","article-title":"Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone","volume":"299","author":"Nemeth EF","year":"2001","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Therapeutic Apheresis and Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1744-9987.2009.00768.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1744-9987.2009.00768.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T07:18:09Z","timestamp":1739344689000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1744-9987.2009.00768.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,17]]},"references-count":35,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1744-9987.2009.00768.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1744-9987.2009.00768.x","archive":["Portico"],"relation":{},"ISSN":["1744-9979","1744-9987"],"issn-type":[{"value":"1744-9979","type":"print"},{"value":"1744-9987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,17]]}}}